| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189766 | Brachytherapy | 2013 | 6 Pages |
Abstract
HDR achieves significantly higher intraprostatic doses while achieving a lower maximum rectal dose compared with our virtual SBRT treatment planning. Future studies should compare clinical outcomes and toxicity between these modalities.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel E. Spratt, Lawrence M. Scala, Michael Folkert, Laszlo Voros, Gil'ad N. Cohen, Laura Happersett, Evangelia Katsoulakis, Michael J. Zelefsky, Marisa A. Kollmeier, Yoshiya Yamada,